Ptc Therapeutics (PTCT) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 0.67.
- Ptc Therapeutics' Asset Utilization Ratio rose 7746.24% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year increase of 7746.24%. This contributed to the annual value of 0.45 for FY2024, which is 1395.88% down from last year.
- According to the latest figures from Q3 2025, Ptc Therapeutics' Asset Utilization Ratio is 0.67, which was up 7746.24% from 0.67 recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Asset Utilization Ratio registered a high of 0.73 during Q1 2025, and its lowest value of 0.2 during Q1 2021.
- Its 5-year average for Asset Utilization Ratio is 0.44, with a median of 0.41 in 2022.
- Per our database at Business Quant, Ptc Therapeutics' Asset Utilization Ratio plummeted by 4118.19% in 2024 and then surged by 7746.24% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' Asset Utilization Ratio stood at 0.27 in 2021, then soared by 55.97% to 0.43 in 2022, then skyrocketed by 39.58% to 0.59 in 2023, then plummeted by 41.18% to 0.35 in 2024, then soared by 92.84% to 0.67 in 2025.
- Its Asset Utilization Ratio stands at 0.67 for Q3 2025, versus 0.67 for Q2 2025 and 0.73 for Q1 2025.